Intelligence Platform
Patents
Browse 2,432 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 12384753
17-beta-hydroxysteroid dehydrogenase type 13 inhibitors and methods of use thereof
granted patentUS 12384750
Ras inhibitors
granted patentUS 12383582
Methods of treating chronic wounds with amniotic fluid having elevated levels of tissue in
granted patentUS 12384761
Imidazolo indazole compounds as JAK inhibitors
granted patentUS 12378241
Pyridine derivative as FGFR and VEGFR dual inhibitors
granted patentUS 12378201
Histone demethylase inhibitors for treating cancers
granted patentUS 12377078
Viral inhibitors, the synthesis thereof, and intermediates thereto
granted patentUS 12378231
Small molecules as monoacylglycerol lipase (MAGL) inhibitors, compositions and use thereof
granted patentUS 12371435
Substituted imidazo[1,2-c]pyrimidines as PRC2 inhibitors
granted patentUS 12371434
MLL1 inhibitors and anti-cancer agents
granted patentUS 12365688
Substituted pyrazolopyrazines, imidazopyrazines and [1,2,4]triazolopyrazines as allosteric
granted patentUS 12365664
Small molecule inhibitors of SRC tyrosine kinase
granted patentUS 12365659
Non-polyamine based polyamine transport inhibitors and their use in the treatment of human
granted patentUS 12364688
NSD family inhibitors and methods of treatment therewith
granted patentUS 12365653
Small molecule inhibitors of lactate dehydrogenase and methods of use thereof
granted patentUS 12357650
Methods and compositions for cancer therapies that include delivery of halogenated thymidi
granted patentUS 12358892
Metalloenzyme inhibitors for treating cancers, Alzheimer's disease, hemochromatosis, and o
granted patentUS 12358896
LRRK2 inhibitors and methods of making and using thereof
granted patentUS 12343380
Expansion of TILs utilizing AKT pathways inhibitors
granted patentUS 12338242
TYK2 inhibitors and uses thereof
granted patentUS 12329748
Anhydrous compositions of mTOR inhibitors and methods of use
granted patentUS 12331056
SHP2 phosphatase inhibitors and methods of use thereof
granted patentUS 12331026
Sulfonamido derivatives as cyclin-dependent kinase 2 inhibitors
granted patentUS 12331036
Heterocyclic RIP1 kinase inhibitors
granted